Leen AM - Search Results

1

Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing.

Shafer P, Leung WK, Woods M, Choi JM, Rodriguez-Plata CM, Maknojia A, Mosquera A, Somes LK, Joubert J, Manliguez A, Ranjan R, Burt B, Lee HS, Zhang B, Fuqua S, Rooney C, Leen AM, Hoyos V. Shafer P, et al. Among authors: leen am. Cytotherapy. 2024 Mar;26(3):266-275. doi: 10.1016/j.jcyt.2023.12.002. Epub 2024 Jan 15. Cytotherapy. 2024. PMID: 38231165 Free article.

2

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

Meij P, Leen A, Rickinson AB, Verkoeijen S, Vervoort MB, Bloemena E, Middeldorp JM. Meij P, et al. Int J Cancer. 2002 May 1;99(1):93-9. doi: 10.1002/ijc.10309. Int J Cancer. 2002. PMID: 11948498 Free article.

3

Progress and prospects: gene therapy clinical trials (part 2).

Aiuti A, Bachoud-Lévi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High KA, Leen AM, Lemoine NR, McNeish IA, Meneguzzi G, Peschanski M, Roncarolo MG, Strayer DS, Tuszynski MH, Waxman DJ, Wilson JM. Aiuti A, et al. Among authors: leen am. Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033. Gene Ther. 2007. PMID: 17984995 Review.

4

T-cell therapy: the next generation.

Leen AM. Leen AM. Expert Rev Hematol. 2010 Apr;3(2):123-5. doi: 10.1586/ehm.10.10. Expert Rev Hematol. 2010. PMID: 21083454 No abstract available.

5

Enhancing immune reconstitution: from bench to bedside.

van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM. van Den Brink M, et al. Among authors: leen am. Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S79-83. doi: 10.1016/j.bbmt.2012.09.016. Epub 2012 Oct 3. Biol Blood Marrow Transplant. 2013. PMID: 23041603 Free article. Review. No abstract available.

6

T-cell therapy: a powerful tool for the management of viral infections and relapse post hematopoietic stem cell transplantation.

Kaloyannidis P, Leen AM, Papadopoulou A. Kaloyannidis P, et al. Among authors: leen am. Expert Rev Hematol. 2012 Oct;5(5):471-3. doi: 10.1586/ehm.12.38. Expert Rev Hematol. 2012. PMID: 23146049 No abstract available.

7

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers.

Luke JM, Vincent JM, Du SX, Gerdemann U, Leen AM, Whalen RG, Hodgson CP, Williams JA. Luke JM, et al. Among authors: leen am. Gene Ther. 2011 Apr;18(4):334-43. doi: 10.1038/gt.2010.149. Epub 2010 Nov 25. Gene Ther. 2011. PMID: 21107439 Free PMC article.

8

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.

Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Blood. 2004 Feb 1;103(3):1011-9. doi: 10.1182/blood-2003-07-2449. Epub 2003 Oct 2. Blood. 2004. PMID: 14525768 Free article.

9

Adoptive immunotherapy for posttransplantation viral infections.

Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. Bollard CM, et al. Biol Blood Marrow Transplant. 2004 Mar;10(3):143-55. doi: 10.1016/j.bbmt.2003.09.017. Biol Blood Marrow Transplant. 2004. PMID: 14993880 Free article. Review.

10

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.

Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, Vignali D, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Blood. 2004 Oct 15;104(8):2432-40. doi: 10.1182/blood-2004-02-0646. Epub 2004 Jul 20. Blood. 2004. PMID: 15265797 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page